Rates bite, equities steady
The session opened on Iran/Israel headlines, then snapped back to the usual routine: index buyers showed up, and the real signal came from rates. Equities stabilized after last week’s AI wobble, but precious metals took the cleanest hit.
Gold logged its worst drop since March after the May U.S. jobs report beat expectations and nudged the market toward higher-for-longer pricing. Stronger yields and a firmer dollar do what they always do to non-yielding assets: they get sold. The geopolitical bid that had been propping up gold during the initial flare didn’t last once risk appetite returned. Silver followed the same path. Oil caught a brief lift from the conflict backdrop, but it didn’t drive positioning.
Bottom line: risk-on in index land, but the push came from rates, not a lasting war premium.
Deals and actions
Capital markets looked a touch more functional. Today’s prints weren’t tradeable (both are pre-listing), but the posture matters: underwriters are leaning back into risk instead of acting like every deal is radioactive.
- Quantum Space (QS): flat / pre-listing on plans to go public via a $1.2B SPAC merger.
- Bending Spoons (Vimeo/Evernote/AOL parent): flat / pre-listing after filing for a U.S. IPO, pointing to increased sales.
Corporate actions kept moving individual names:
- EHang (EHANG) +6% after approving a $30M stock buyback. Small-cap buybacks are blunt, but effective: they signal management’s view on valuation and add a mechanical bid in thin liquidity.
- In Europe, the bank consolidation soap opera rolled on: Intesa moved to bid for Monte dei Paschi, pushing back on Banco BPM’s earlier proposal and keeping the theme alive.
- Alliance Resource Partners (ARLP) flat after agreeing to buy oil and gas royalty interests for $206M. The tape treated it as “show me the returns,” not a reason to chase the stock.
Earnings still punish
Even with the broader tape steady, single-name downside stayed sharp wherever forward visibility cracked.
Wix (WIX) fell after warning on revenue and future bookings. Bookings is the tell: it forces a reset on near-term demand and puts the growth path back on trial. Software isn’t getting much leeway for demand wobbles, and sellers acted accordingly.
FuelCell Energy sold off on a double miss: non-GAAP EPS -$0.53 (miss -$0.10) and revenue $35.59M (miss -$4.92M). For unprofitable energy-transition names, the revenue line is the pulse. Miss there and the cash-burn math gets uglier fast.
The rest of the tape was more incremental than catalytic:
- Alaska Air said it’s nearing a point where it can issue financial guidance again—a visibility milestone, not a rerating by itself.
- Cognizant picked up an upgrade at Wedbush.
- General Motors got airtime for the longest-running “Strong Buy” analyst streak in consumer discretionary—fun trivia, not a new driver.
Healthcare leadership stayed with GLP-1s. Novo Nordisk’s Wegovy pill continues to lead the U.S. GLP-1 pill market even as competition shows up. In this category, brand, prescriber habit, and supply reliability matter more than people like to model, and leaders can hold the lane longer than expected.
What mattered
- Rates hit metals: gold and silver rolled after a firm jobs print pushed yield expectations higher.
- Risk tone improved: issuance chatter and corporate actions looked normal again.
- Stock-specific punishment remains: WIX bookings and FCEL execution got hit hard.
- GLP-1 leadership persists: Novo is still setting the pace in the pill race.
Markets were calm on the surface, but the message was blunt: if rates move against you, the tape won’t wait for a better story.